Mylan Recalls Acamprosate Calcium Tablets Over Dissolution Failure
FDA classifies recall of one lot of acamprosate calcium 333 mg tablets as Class II due to failed dissolution specifications.
Recalls & Safety Alerts in West Virginia
Every recalls & safety alerts report published for West Virginia, newest first.
FDA Closes Recall of Mylan Mycophenolate Mofetil Injection
The FDA has closed the Class II recall of a Mylan Pharmaceuticals injection due to the presence of precipitate.